STAT Plus: Consumer groups and unions try again to block the AbbVie and Allergan merger
A coalition of consumer groups and unions hopes to convince the Federal Trade Commission to…
Author: STAT
Watch: What patients and their families learned from facing a deadly disease
Dr. David Fajgenbaum went from being a healthy third-year medical student to suddenly suffering multi-organ-system…
.jpg)
Watch: VCs have to predict the future. Here’s what three of them expect next in biotech
Biotech venture capitalists make their money by seeing the future better than most of us,…
Sanofi announces it will work with HHS to develop coronavirus vaccine
The drug maker Sanofi Pasteur is entering the race to develop a vaccine to protect…
STAT Plus: Pharmalittle: Coronavirus clinical trials are going slower than hoped; opioid lawsuit payouts may be less than expected
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Welcome to the STAT China newsletter
A version of this story first appeared in the weekly STAT China newsletter. To receive…
STAT Plus: ‘Pharma doesn’t like fish oil’: Wall Street funds sold Amarin after big win with heart drug
Wall Street fund managers lightened their stock positions in Amarin (AMRN) during the fourth quarter…
.jpg)
Opinion: Without oversight, electronic prescribing can harm patients
The use of electronic health record systems in doctors’ offices and hospitals has hit a…
Opinion: FDA calls states’ bluffs on drug importation
For decades, critics of the U.S. drug pricing system have advocated importing drugs from Canada…
There’s no one-size-fits-all for healthy physician bodies. Why don’t ads for trendy medical scrubs reflect that?
Last year I treated a young patient struggling with body image issues. This child’s parents…
STAT Plus: Microbiome-based drug makers are hoping new late-stage data will pull the field out of the shadows
The microbiome industry is on the cusp of a turning point. Seres Therapeutics, one of…
Opinion: For African women at risk of HIV, a woke world is still sound asleep
The arrival in 2012 of a daily pill to prevent HIV infection was widely hailed…
Opinion: Why medical school should start at age 28
American medicine is at a crossroads as doctors begin to reject a cruel, exhausting educational…
The global responders: Who is leading the charge against the coronavirus outbreak
As concerns mount over the coronavirus that first emerged in China, public health officials there…
STAT Plus: A city in Georgia is the latest to sue Mallinckrodt over its pricey Acthar Gel medicine
The city of Marietta, Ga., has joined a growing list of unions and local governments…
Are e-cigarette companies helping smokers quit? Survey suggests Americans don’t buy it
WASHINGTON — E-cigarette companies have been trying for years to rebrand as a public health…
Opinion: Cheers and jeers as med school’s Step 1 test becomes pass/fail
Medical students around the country cheered and jeered this week’s announcement that the results of…
STAT Plus: Pharmalittle: Generic shortages loom as coronavirus worsens; Connecticut lawmakers look to cap insulin costs
And so, another working week will soon draw to a close. Not a moment too…
Opinion: The coronavirus outbreak exposes the U.S.’s pharma supply chain vulnerability
In the 21st century, Americans have found it far too easy to be complacent about…
STAT Plus: A longtime health care investor recalls the insulin bong, praises discipline in valuations, and looks to South America
Les Funtleyder is a longtime health care investor who started his professional investing career just…
Disease modelers gaze into their computers to see the future of Covid-19, and it isn’t good
At least 550,000 cases. Maybe 4.4 million. Or something in between. Like weather forecasters, researchers…
STAT Plus: Americans with employer coverage saw growth in drug spending outpace other medical costs
Americans with private employer health insurance spent nearly 26% more on prescription drugs from 2014…
The Zolgensma lottery, billionaire philanthropy, & life on the buy side
What’s the right way to give drugs away? Is $3 billion even a lot of…
Weight-loss drug to be pulled from market after FDA expresses concerns on cancer risk
The Japanese drug maker Eisai on Thursday said it would withdraw the weight-loss drug Belviq…
Webinar: From computer to clinic: The challenges of implementing artificial intelligence in practice
It’s one thing to train an algorithm to produce headline-grabbing results on paper. It’s quite…
Health apps collecting sensitive data need more transparent terms of service, law experts argue
We’ve all been there. We’ve downloaded a new app or visited a website that requires…
STAT Plus: As opioid crisis intensified, many family doctors found promotional pitches were very good
As the opioid crisis accelerated a decade ago, pharmaceutical sales reps emphasized the benefits of…
STAT Plus: Pharmalittle: India struggles with coronavirus; CVS and Sanofi shake up management
Top of the morning to you, and a fine one, it is. Despite another round…
Opinion: From bench to bedside, biologics require excellence at every stage
The Nobel Prize in Medicine will never be awarded for excellence in the formulation and…
Opinion: Federated learning: collaboration without compromise for health care research
What if we could learn from massive collections of data while avoiding the privacy and…
Opinion: STAT Plus: Why medtech is a different beast than biotech in the life sciences pack
Biotech innovations dominate the life science news cycle — think CRISPR for gene editing or…
Watch: Why reports about coronavirus death rates can be misleading
When a new disease starts to spread, the most pressing questions are: How deadly is…
CDC director: More person-to-person coronavirus infections in U.S. likely, but containment still possible
Health officials believe there is still opportunity to prevent widespread transmission of the coronavirus in…
STAT Plus: Insulin makers object to FDA proposal for speeding arrival of biosimilar insulins
Amid growing rancor over the cost of insulin, two of the largest manufacturers are objecting…
STAT Plus: Pharmalittle: Big pharma isn’t stepping up to make a coronavirus vaccine; Chinese drug maker threatens Gilead patent
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT Plus: After a new version of a decades-old drug gets orphan status, the price suddenly skyrockets
For years, hospitals and clinics have used an injectable medicine called dehydrated alcohol to treat…
Opinion: Paying gestational carriers should be legal in all states
Every year, hundreds of thousands of babies are born in the U.S. using assisted reproductive…
Opinion: A daughter’s plea: Doctors must stop shirking palliative care
The first time I lost my dad was in 2010, just a few weeks after…
Watch: Hollywood motion capture technology finds a new role in hospital rehab
A technology most famous for its use in Hollywood movies is now a rehabilitation tool…
STAT Plus: New life for an old battle: Trump plan to remove tobacco regulation from FDA draws fire
An earlier version of this story first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the…
Understanding pandemics: What they mean, don’t mean, and what comes next with the coronavirus
The word “pandemic” is not a comforting one. And yet it is increasingly being bandied…
Major drug makers haven’t stepped up to manufacture coronavirus vaccine, top U.S. health official says
WASHINGTON — No major pharmaceutical company has come forward to say it would manufacture a…
STAT Plus: WHO adviser says an antimicrobial fund can help a market that ‘needs to be fixed’
Over the past month, the World Health Organization and the Access to Medicines Foundation issued…
Disease caused by the novel coronavirus officially has a name: Covid-19.
The disease caused by the novel coronavirus has a name: Covid-19. Tedros Adhanom Ghebreyesus, the…
Opinion: Hospitals, governments need more data to prepare for the new coronavirus outbreak
In the six weeks since an outbreak of a novel coronavirus was first recognized in…
STAT Plus: Pharmalittle: Trump considers executive action to cut drug prices; feds ‘not done’ with generic price-fixing probe
Rise and shine, everyone, another busy day is on the way. We can tell because…
Opinion: A strategy for securing religious freedom and tolerance in health care
A new rule proposed by the Department of Health and Human Services in mid-January, “Ensuring…
Opinion: What an 1890s opioid epidemic can teach us about ending addiction today
In the ’90s, chronic pain was rampant in America. Opioids, which had previously been taboo,…
In reelection bid, a GOP lawmaker campaigns on Pelosi’s drug pricing bill
WASHINGTON — In the months before House Democrats passed their aggressive drug negotiation bill, GOP…
STAT Plus: U.S. biotechs fear the coronavirus outbreak will delay their China-based research
Biotech investors and executives are growing worried that restrictions intended to contain the coronavirus epidemic…